Merck-Pfizer Alliance Joins Syndax on Ovarian Cancer

07.01.2016 - Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...